Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ViaLogy selected by Cisco

1 Apr 2008 13:00

ViaLogy PLC01 April 2008 ViaLogy Technology Integrated into New Cisco Open Platform for Safety and Security London, 1 April 2008: ViaLogy PLC (LSE: VIY), a leading innovator of real-timenetwork-centric signal processing platforms, announces its technology is beingintegrated into the Cisco Open Platform for Safety and Security (COPSS), the newCisco technology platform launched today at the annual FOSE 2008 industry tradeshow. The Cisco Open Platform for Safety and Security is a secure, intelligent,converged solution intended for multiple surveillance and alert applications tosupport the growing needs of defence, civilian, public safety, state and localgovernment agencies. It is to be offered by Cisco to public sector organizationson a worldwide basis. As a core member of the solution team, ViaLogy will provide the sensorintegration engine for the platform. ViaLogy's SPMTM (Sensor Policy Manager)software enables disparate sensors in very large enterprise networks to processand report only key events of interest to security personnel. The ViaLogytechnology is sensor agnostic and considerably enhances the performance andstrength of all integrated legacy and IP sensors, thus avoiding false alarms,missed events and optimizing use of limited bandwidth. ViaLogy's SPMTM is anintegral part of the Cisco Open Platform for Safety and Security demonstration -and available for viewing - at Cisco's Center of Excellence in Herndon,Virginia. "We are pleased to be working with Vialogy as part of our go-to-market team forthe Cisco Open Platform for Safety and Security," said Bruce Klein, Cisco'sfederal vice president. "Our strategy is to pull together an 'ecosystem' of theleading companies with expertise in protecting citizens, employees and criticalassets to provide the most comprehensive solution for facilitating collaborationfor government agencies. Vialogy delivers a critical piece of our overalltechnology platform." "Cisco has developed the Cisco Open Platform for Safety and Security to answer aworldwide requirement from customers for improved and co-ordinated integratedsafety and security systems," said Robert W. Dean. President and CEO of ViaLogy,"We are proud to be chosen as an approved supplier to the platform." "SPMTM is a comprehensive and flexible product that can be customised to suitindividual customer needs because we recognise that there are a variety ofsituations to be dealt with. Some customers will want a complete system forsecuring or monitoring a new building or area, others will want the overallintegration of existing and new security arrangements. "The Cisco Open Platform for Safety and Security will give common operationalpicture vigilance of all aspects of security, faster situation assessment,automated decision making and improved response time." ViaLogy has been closely involved in the development of an Improved DecisionSupport System for disparate sensors. As the Department of Defense drivesconvergence of physical security, consequence management and Chemical,Biological, Radiological/Nuclear, and Explosive (CBRNE) incidents to ensuresafety of military bases, scaleable network-centric technologies and IT productsare becoming increasingly important. ViaLogy has demonstrated its successes overthe past year during multiple Department of Defense demonstrations thatcontinually monitored and reported on CBRNE sensors in realistic scenarios.ViaLogy's SPMTM technology flawlessly linked all critical sensors to enableautomatic time alerts to the right person. This sensor integration andinteroperability capability will be a critical factor in next generationnetworked emergency alert systems. To find out more about the Cisco Open Platform for Safety and Security andViaLogy's participation please visit www.vialogy.com. ends Further information from: ViaLogy Robert W Dean, President/CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)Terry Bond, Chairman - UK & Europe +44 (0)1235 834734 Nominated Advisor (Seymour Pierce)Mark Percy +44 (0)20 7107 8000 PR Consultants - Redleaf CommunicationsSamantha Robbins / Anna Dunkin +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications and sensor fusion. ViaLogy is currentlydeploying and designing computational systems, powered by its patentedtechnologies, for applications in life sciences, public safety and security,surveillance, defence and geoseismology. Vialogy focuses on market drivenproblems where automation, timeliness, quality and reliability of informationprocessing are essential. ViaLogy's core competency incorporates rapidly andaccurately detecting weak signals buried in high noise background and clutter.This technology can be employed to solve problems involving sensor integrationand information overload challenges involving video, telephony and controlsensors, as well as for enhancement of numerous signal processing applications.For more information, visit our website at www.vialogy.com. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.